TOMORROW’S TECHNOLOGY and HEALTH CARE... TODAY!

At WGG, we aim to build a great sustainable and equitable portfolio of investment in emerging market through advanced research, acquisition, production and services commercialized through our divisions.

WELCOME TO WUHAN GENERAL GROUP

About Our Company

Through its divisions, WGG is focus in emerging technology and in medical cannabis and cannabidiol (CBD) sectors. Through acquisitions, Wuhan will enter the international 146.4 billion growing cannabis market for the medical applications such as cancer, mental disorders, chronic pain, and others is expected to propel revenue growth in Canada, the United States, and Europe.

READ MORE ABOUT OUR COMPANY

People

Being an employer of choice and developing the leadership and organizational capacity within our talent pool to deliver on our long-term strategies.

Growth and performance

Sustaining or exceeding our historical revenue and organic growth performance, supplemented by acquisitions, while achieving strong margins.

Clients

Building a strong brand presence with our target audiences, and acting as their technology provider of choice by delivering an integrative, innovative client experience.

Shareholder value

Aligning our capital structure and investments to keep the business strong. Offer the distribution of dividends